US Broker Ratings

Neuronetics, Inc. (STIM) Stock Analysis: A Healthcare Gem with a 226% Upside

In the competitive landscape of healthcare, Neuronetics, Inc. (STIM) is making waves as a promising player within the medical devices industry. Specializing in neurohealth treatments, this U.S.-based company is drawing..

Absci Corporation (ABSI): Investor Outlook on a Potential 166% Upside in AI-Driven Biotech

Absci Corporation (NASDAQ: ABSI), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its innovative approach to drug creation. This Vancouver-based company is not only..

Exxon Mobil Corporation (XOM) Investor Outlook: Navigating Market Volatility with Strategic Insights

Exxon Mobil Corporation (NYSE: XOM), a global titan in the energy sector, has long been an integral player in the oil & gas integrated industry. With a commanding market capitalization..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring a 37% Potential Upside in Biotechnology

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) stands at a compelling juncture in the biotechnology sector, attracting investor interest with its specialized focus on hematologic disorders and cancer therapies. With a market..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 7.27% Potential Upside Amidst Strong Dividend Yield

TotalEnergies SE (NYSE: TTE), a leader in the integrated oil and gas industry, presents an intriguing proposition for investors seeking both stability and growth in the energy sector. With a..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 107% Potential Upside with Analyst Confidence

ClearPoint Neuro Inc. (NASDAQ: CLPT), a burgeoning entity within the healthcare sector, is capturing investor attention with its robust potential upside and promising analyst endorsements. Specializing in medical devices, ClearPoint..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a Potential 96.64% Upside

Benitec Biopharma Inc. (NASDAQ: BNTC) is a noteworthy player in the biotechnology sector, focusing on the cutting-edge intersection of RNA interference and gene therapy. As a clinical-stage company headquartered in..

Olema Pharmaceuticals (OLMA) Stock Analysis: A 72% Upside Potential in the Biotech Sector

Investors looking for promising opportunities in the biotechnology sector should consider Olema Pharmaceuticals, Inc. (NASDAQ: OLMA). This clinical-stage biopharmaceutical company, headquartered in San Francisco, is dedicated to pioneering therapies for..

Chevron Corporation (CVX)

⚠️ No article content returned.

..

Zhengye Biotechnology (ZYBT) Stock Analysis: A Closer Look at Market Challenges and Opportunities

Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT), a player in the healthcare sector specializing in veterinary vaccines, is currently navigating a challenging market environment. With its primary focus on the Chinese..

NeoGenomics, Inc. (NEO) Stock Analysis: Unpacking a 12.81% Upside Potential Amidst Healthcare Diagnostics Growth

NeoGenomics, Inc. (NASDAQ: NEO) stands as a significant player in the healthcare industry, specifically within the diagnostics and research sector. This Fort Myers, Florida-based company operates an extensive network of..

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a Focused Healthcare Model

Investors evaluating agilon health, inc. (NYSE: AGL) are presented with a unique opportunity within the healthcare sector, specifically in the medical care facilities industry. As a company dedicated to enhancing..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 23% Upside Potential in the Medical Device Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a notable player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention. With its headquarters in Alajuela, Costa Rica,..

Evolent Health (EVH): Can This Healthcare Innovator Deliver a 154% Upside?

Evolent Health, Inc. (EVH), a healthcare innovator headquartered in Arlington, Virginia, is at a pivotal juncture that could offer a remarkable investment opportunity. With its current stock trading at $3.77..

BioLife Solutions, Inc. (BLFS): Investor Outlook with a 32.86% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading player in the healthcare sector’s medical instruments and supplies industry, has been attracting considerable attention from investors. With a market capitalization of $1.18..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a Healthcare Innovation with a Potential 8.75% Upside

Azenta, Inc. (NASDAQ: AZTA), a stalwart in the healthcare sector, has been making waves in the medical instruments and supplies industry. With a market capitalization of $1.84 billion, Azenta has..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A 12.62% Upside Potential Amid Sector Growth

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands out in the medical care facilities industry with a market capitalization of $1.38 billion, positioning itself as a significant player in the U.S...

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Leader with 133.86% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is capturing the attention of investors with its innovative approach to RNA medicine and a remarkable potential upside of 133.86%...

Supernus Pharmaceuticals (SUPN) Stock Analysis: Exploring a 22.67% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a prominent player in the healthcare sector, specializes in developing and commercializing treatments for central nervous system (CNS) diseases. With a market capitalization of $2.87..

Integra LifeSciences Holdings C (IART) Growth Potential: Exploring a 24.9% Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors looking for growth potential within a challenging..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds